Full Data
?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets
Join Now!
Need this critical market data?
Access thousands of market events, data points, and news articles!
Already have an account?
Login
Home » News » Hengrui Medicine's 2021: Challenge the continuous revenue decline for the first time, firmly innovate and invest more than 6 billion yuan in research and development.